These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12080182)

  • 1. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.
    Colciaghi F; Borroni B; Pastorino L; Marcello E; Zimmermann M; Cattabeni F; Padovani A; Di Luca M
    Mol Med; 2002 Feb; 8(2):67-74. PubMed ID: 12080182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
    Colciaghi F; Marcello E; Borroni B; Zimmermann M; Caltagirone C; Cattabeni F; Padovani A; Di Luca M
    Neurology; 2004 Feb; 62(3):498-501. PubMed ID: 14872043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
    Tang K; Hynan LS; Baskin F; Rosenberg RN
    J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of ADAM10 are reduced in Alzheimer's disease CSF.
    Sogorb-Esteve A; García-Ayllón MS; Gobom J; Alom J; Zetterberg H; Blennow K; Sáez-Valero J
    J Neuroinflammation; 2018 Jul; 15(1):213. PubMed ID: 30045733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients.
    Bram JMF; Talib LL; Joaquim HPG; Sarno TA; Gattaz WF; Forlenza OV
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):963-972. PubMed ID: 29845446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
    Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
    Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease.
    Manzine PR; Barham EJ; Vale FA; Selistre-de-Araújo HS; Pavarini SC; Cominetti MR
    Int J Geriatr Psychiatry; 2014 Apr; 29(4):414-20. PubMed ID: 23970375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease.
    Pereira Vatanabe I; Peron R; Mantellatto Grigoli M; Pelucchi S; De Cesare G; Magalhães T; Manzine PR; Figueredo Balthazar ML; Di Luca M; Marcello E; Cominetti MR
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging.
    Schuck F; Wolf D; Fellgiebel A; Endres K
    J Alzheimers Dis; 2016; 50(3):817-26. PubMed ID: 26757187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer's disease.
    Agüero P; Sainz MJ; García-Ayllón MS; Sáez-Valero J; Téllez R; Guerrero-López R; Pérez-Pérez J; Jiménez-Escrig A; Gómez-Tortosa E
    Alzheimers Res Ther; 2020 Oct; 12(1):139. PubMed ID: 33129344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).
    Bermejo-Bescós P; Martín-Aragón S; Jiménez-Aliaga K; Benedí J; Felici E; Gil P; Ribera JM; Villar AM
    Neurochem Res; 2013 Jul; 38(7):1415-23. PubMed ID: 23575575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
    Olsson A; Höglund K; Sjögren M; Andreasen N; Minthon L; Lannfelt L; Buerger K; Möller HJ; Hampel H; Davidsson P; Blennow K
    Exp Neurol; 2003 Sep; 183(1):74-80. PubMed ID: 12957490
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Agüero-Rabes P; Pérez-Pérez J; Cremades-Jimeno L; García-Ayllón MS; Gea-González A; Sainz MJ; Mahillo-Fernández I; Téllez R; Cárdaba B; Sáez-Valero J; Gómez-Tortosa E
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
    Harris B; Pereira I; Parkin E
    Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly.
    Manzine PR; de França Bram JM; Barham EJ; do Vale Fde A; Selistre-de-Araújo HS; Cominetti MR; Iost Pavarini SC
    Dement Geriatr Cogn Disord; 2013; 35(1-2):58-66. PubMed ID: 23306532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain.
    Marcinkiewicz M; Seidah NG
    J Neurochem; 2000 Nov; 75(5):2133-43. PubMed ID: 11032903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.
    Qin W; Ho L; Wang J; Peskind E; Pasinetti GM
    PLoS One; 2009; 4(1):e4183. PubMed ID: 19159013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.
    Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR
    Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM10 expression and promoter haplotype in Alzheimer's disease.
    Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
    Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.